|
ZNF518A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.15589809630046E-11 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
4.13220013761872E-10 |
| Stage1-vs-Stage2 |
7.639200E-01 |
| Stage1-vs-Stage3 |
8.257200E-03 |
| Stage1-vs-Stage4 |
2.609200E-01 |
| Stage2-vs-Stage3 |
1.103360E-01 |
| Stage2-vs-Stage4 |
4.383800E-01 |
| Stage3-vs-Stage4 |
7.641000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.60780000002525E-06 |
| Normal-vs-Asian |
2.2609000227547E-09 |
| Caucasian-vs-AfricanAmerican |
4.103600E-01 |
| Caucasian-vs-Asian |
1.924590E-01 |
| AfricanAmerican-vs-Asian |
9.103800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59772195473806E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.026600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.95499172406244E-12 |
| Normal-vs-Age(81-100Yrs) |
1.006830E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.362200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.603800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.669800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.473000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.432400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.171800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.22850000172647E-08 |
| Classical-VS-Follicular |
4.852300E-02 |
| Classical-VS-Other |
6.382000E-01 |
| Classical-VS-Normal |
2.02637906454584E-12 |
| Tall-VS-Follicular |
9.32160004740723E-09 |
| Tall-VS-Other |
1.410590E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.872400E-01 |
| Follicular-VS-Normal |
4.8046000511448E-09 |
| Other-VS-Normal |
9.637200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.49140000016423E-07 |
| N0-vs-N1 |
6.257600E-01 |
|
|
